Mid-Race Incident Relegates Reed to 32nd-Place Finish

JOLIET, Ill.  (September 17, 2016) – Roush Fenway Racing driver Ryan Reed and the No. 16 Lilly Diabetes/American Diabetes Association team finished 32nd on Saturday at Chicagoland Speedway in the last regular season race before the Chase for the 2016 NASCAR XFINITY Series Championship. Reed’s race was cut short on Lap 101 when contact with the No. 42 sent Reed into the wall. The damage was too severe to repair.

“It’s a frustrating result,” said Reed.  “We were battling all race and it’s a shame to have your day end the way that it did but we’ll just have to move on. I’m excited to start The Chase next week in Kentucky.”

Reed led the Roush Fenway qualifying effort Saturday morning, advancing to the second round of NXS qualifying and placing 14th. He took the green flag and immediately began moving forward, advancing to the 11th position before the Lap 25 competition caution.

The No. 16 Lilly Diabetes Mustang began to free up during the subsequent green flag run, but Reed would battle to maintain a top-12 position. The green flag run continued before he brought out a caution, spinning while attempting to enter pit road on lap 82.

Restarting in the tenth position on Lap 88, Reed gained a spot on the restart before another quick caution came out for fluid in turn 3. He would restart ninth on Lap 95, but was shuffled back on the restart to 11th .

On Lap 101, Reed and the No. 42 car made contact which sent the Lilly Diabetes Mustang into the wall. The massive damage to the right side was too much to repair, ending Reed’s race early.

After today’s race, Reed remains 10th in the NASCAR XFINITY Series championship standings and has locked in to compete in the NASCAR XFINITY Series Chase.

Reed and the rest of the NASCAR XFINITY Series will be back on track on Saturday, September 24th at Kentucky Speedway.

About the Drive to Stop Diabetes

The Drive to Stop Diabetes campaign strives to educate people about living well with diabetes. The campaign encourages the millions of Americans who have diabetes to talk about it with their doctor, family, and friends and to actively manage their health.

About Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com or follow us on Twitter: @LillyDiabetes.

About The American Diabetes Association

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, the Association’s mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.